Abstract
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by the development of endocrine and nonendocrine tumors. The genetic anomaly underlying the tumorigenesis in MEN1 is loss-of-function mutations of the MEN1 gene. Endocrine tumors in MEN1 patients can be clinically apparent at very young ages, which is why a thorough and regular follow-up of all potentially affected individuals is required.
We report the case of an 18-year-old man who was clinically diagnosed with MEN1 based on the presence of primary hyperparathyroidism, incidentally discovered during a hospitalization for acute appendicitis. The subsequent detailed workup revealed that the patient already also had pituitary and pancreatic lesions. The patient belongs to a MEN1 family in which several members refused genetic testing. He was hence unaware of his familial genetic background and had never been subjected to any screening tests.
This case exhibits the classic triad of MEN1 manifestations (primary hyperparathyroidism, pancreatic neuroendocrine tumors, and pituitary adenoma) and illustrates the importance of early genetic and clinical diagnosis.
This is a preview of subscription content, log in via an institution to check access.
References
Beckers A, Betea D, Valdes Socin H, Stevenaert A. The treatment of sporadic versus MEN1-related pituitary adenomas. J Intern Med. 2003. https://doi.org/10.1046/j.1365-2796.2003.01164.x.
Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001. https://doi.org/10.1210/jcem.86.12.8070.
Burgess JR, Parameswaran V, David R, Greenaway TM, Shepherd JJ. The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 1998. https://doi.org/10.1001/archsurg.133.2.126.
Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, et al. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res. 2009. https://doi.org/10.1359/jbmr.090304.
Gonçalves TD, Toledo RA, Sekiya T, Matuguma SE, Maluf Filho F, Rocha MS, et al. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life. J Clin Endocrinol Metab. 2014. https://doi.org/10.1210/jc.2013-1768.
Stratakis CA, Schussheim DH, Freedman SM, Keil MF, Pack SD, Agarwal SK, et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2000. https://doi.org/10.1210/jcem.85.12.7064.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012. https://doi.org/10.1210/jc.2012-1230.
Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, et al. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol. 2006. https://doi.org/10.1111/j.1572-0241.2006.00367.x.
Tonelli F, Giudici F, Cavalli T, Brandi ML. Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: total versus partial parathyroidectomy. Clinics. 2012. https://doi.org/10.6061/clinics/2012(Sup01)26.
Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, et al. Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg. 2006. https://doi.org/10.1097/01.sla.0000197715.96762.68.
Triponez F, Sadowski SM, Pattou F, Cardot-Bauters C, Mirallié E, Le Bras M, et al. Long-term follow-up of MEN1 patients who do not have initial surgery for small ≤2 cm nonfunctioning pancreatic neuroendocrine tumors, an AFCE and GTE study. Ann Surg. 2018. https://doi.org/10.1097/SLA.0000000000002191.
Vergès B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab. 2002. https://doi.org/10.1210/jcem.87.2.8145.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Delannoy, P., Potorac, I., Beckers, A. (2021). Multiple Endocrine Neoplasia Type 1 in Clinical Practice. In: Colao, A., Jaffrain-Rea, ML., Beckers, A. (eds) Polyendocrine Disorders and Endocrine Neoplastic Syndromes. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-73082-0_19-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-73082-0_19-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73082-0
Online ISBN: 978-3-319-73082-0
eBook Packages: Springer Reference MedicineReference Module Medicine